# CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer

> **NCT01985828** · NA · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 83 (actual)

## Conditions studied

- Prostate Adenocarcinoma

## Interventions

- **RADIATION:** CyberKnife
- **OTHER:** Androgen Deprivation Therapy (ADT)
- **RADIATION:** Intensity Modulated radiation therapy (IMRT)

## Key facts

- **NCT ID:** NCT01985828
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11-19
- **Primary completion:** 2018-09
- **Final completion:** 2019-08
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2024-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01985828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01985828, "CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01985828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*